Evaluating Topical Nitric Oxide Formulations Against an Atopic Dermatitis Methicillin-Resistant S. Aureus Isolate in...

Area of Science:

• Dermatology
• Infectious Diseases
• Biomedical Engineering

Background:

• Atopic dermatitis (AD) is linked to impaired skin barrier function, increasing susceptibility to infections like Staphylococcus aureus and methicillin-resistant S. aureus (MRSA).
• Antibiotic resistance and biofilm formation complicate the management of these infections in AD patients.
• Nitric oxide (NO) demonstrates antimicrobial properties and biofilm dispersal capabilities, offering a potential therapeutic alternative.

Purpose of the Study:

• To evaluate the antimicrobial efficacy of topical nitric oxide (NO)-releasing formulations against MRSA infections in a preclinical model.
• To assess the impact of NO formulations on MRSA biofilm reduction in a porcine wound infection model.

Main Methods:

• Three topical NO-releasing formulations at varying concentrations were tested against MRSA isolates from AD patients.
• A porcine partial-thickness wound infection model was used, with wounds inoculated and allowed to form biofilms before treatment.
• Treatments included daily application of NO formulations or vehicle control, with bacterial enumeration at baseline, day 4, and day 7.

Main Results:

• All tested NO formulations significantly reduced MRSA bacterial burden compared to baseline.
• Higher concentrations of NO formulations generally yielded greater reductions in MRSA.
• Specific formulations demonstrated substantial reductions: 20% NO+GEL (99.23%), 16% NO+UNG (>99.5%), and 6% NO+CREAM (99.97%) compared to controls at day 7.

Conclusions:

• Topical NO-releasing treatments exhibit significant antimicrobial efficacy against MRSA infections and biofilms.
• These results support the potential of NO as an alternative antimicrobial strategy for atopic dermatitis.
• Further clinical studies are warranted to confirm the efficacy and safety of NO treatments in AD patients.